pcclchimgp91s lentiviral vector transduced cd34+ cells
Cell therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2011 (NCT01381003)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Stem CellSupplementation
Stem Cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pcclchimgp91s lentiviral vector transduced cd34+ cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07113743 | Phase 1/Phase 2 (Phase 2) | Sep 10, 2025 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT01381003 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2011 | University of London |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2025 |
| University of London | Academic/Hospital | 1 | 1 | 1 | 2011 |
2 organizations
Page 1 / 1